Patients experiencing the primary endpoint were older; had lower BMI and GNRI values; had a lower prevalence of hypertension and dyslipidemia; had lower statin use; and had lower hemoglobin, albumin, HDL-cholesterol, and LDL-cholesterol levels than those who did not experience the primary endpoint. This evidence concerns the gene ALB and hypertensive disorder.